Haemoconcentration of cardiopulmonary bypass blood with Hemosep

• Research type

  Research Study

• Full title

  A randomised controlled pilot study comparing standard fluid management with haemoconcentration of remaining cardiopulmonary bypass blood using the new Hemosep device.

• IRAS ID

  135456

• Contact name

  Andrew A Klein

• Contact email

  Andrew.Klein@nhs.net

• Sponsor organisation

  Papworth Hospital NHS Trust

• Research summary

  In order for patients to safely undergo cardio-pulmonary bypass for heart surgery, their blood must be diluted so that there is enough circulating volume for both the bypass machine and the patient’s body. At the end of bypass this diluted blood is returned to patients. Hemosep can re-concentrate this blood before it is returned to patients. We aim to examine whether concentrating patients blood with Hemosep before returning it leads to higher haematocrit (higher red blood cell concentration) in patients, compared with patients who receive their diluted blood back.

• REC name

  East Midlands - Derby Research Ethics Committee

• REC reference

  13/EM/0326

• Date of REC Opinion

  30 Sep 2013

• REC opinion

  Further Information Favourable Opinion